V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001928 | 230008176 | 1.65 | 46.6 | null | null | 2020-08-24 | null | N | null | DICE TRIAL | 100082218 |
| 230001932 | 230008178 | null | null | null | 2020-09-10 | 2020-09-15 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100578660 |
| 230001933 | 230008179 | 1.56 | 81.1 | Adjuvant (A) | 2018-06-14 | 2018-06-14 | PACLITAXEL | 02 | N | ICON8B TRIAL | 101018266 |
| 230001935 | 230008180 | 1.67 | 92.6 | null | 2020-02-13 | 2020-02-13 | null | 99 | null | CARBOPLATIN + GEMCITABINE | 100539960 |
| 230001936 | 230008181 | null | null | null | 2019-03-29 | 2019-07-05 | null | null | null | CARBOPLATIN + ETOPOSIDE | 100143628 |
| 230001938 | 230008182 | 1.64 | 88.9 | Palliative (P) | 2020-04-20 | 2020-04-20 | Olaparib | 02 | N | OLAPARIB | 101134945 |
| 230001939 | 230008183 | null | null | null | 2016-10-30 | 2016-11-02 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100510619 |
| 230001941 | 230008185 | 1.67 | 53 | null | 2018-03-31 | 2018-03-31 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100644877 |
| 230001942 | 230008186 | null | null | null | 2019-03-23 | 2019-06-18 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100920468 |
| 230001947 | 230008188 | 1.55 | 103.75 | Palliative (P) | null | 2020-04-18 | PACLITAXEL | 02 | null | PACLITAXEL | 100662507 |
| 230001952 | 230008190 | 1.67 | 113 | null | null | 2021-10-20 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101302845 |
| 230001953 | 230008191 | null | 0 | null | 2018-06-04 | 2019-06-26 | Niraparib | 02 | null | NIRAPARIB | 101786368 |
| 230001955 | 230008193 | 1.65 | 81.8 | null | null | 2021-02-06 | Niraparib | 02 | null | NIRAPARIB | 100203421 |
| 230001956 | 230008194 | 1.54 | 65.9 | null | 2019-06-11 | 2019-06-18 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100717977 |
| 230001957 | 230008195 | null | null | null | 2019-07-22 | 2020-01-15 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100273956 |
| 230001959 | 230008196 | 1.62 | 77.3 | null | 2021-05-17 | 2021-05-30 | Niraparib | 02 | null | NIRAPARIB | 100633551 |
| 230001965 | 230008198 | 1.56 | 58.6 | Palliative (P) | 2017-05-05 | 2017-06-17 | null | null | N | ICON8B TRIAL | 100648169 |
| 230001966 | 230008199 | null | null | null | 2020-12-30 | 2021-01-08 | Niraparib | 02 | null | NIRAPARIB | 101170545 |
| 230001971 | 230008200 | 1.64 | 67.4 | null | 2019-09-14 | 2020-03-16 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101171132 |
| 230001976 | 230008201 | null | null | null | 2021-12-08 | 2021-12-12 | null | 02 | null | TRIAL UNSPECIFIED | 101770881 |
| 230001977 | 230008202 | null | null | null | 2021-06-25 | 2021-06-27 | null | null | null | TOPOTECAN | 101623618 |
| 230001978 | 230008203 | 1.71 | 53.8 | null | 2020-06-23 | 2020-07-16 | null | 01 | null | NIRAPARIB | 100327927 |
| 230001982 | 230008205 | null | null | null | 2017-12-04 | 2017-12-07 | null | null | null | CARBOPLATIN | 101163629 |
| 230001984 | 230008206 | 1.57 | 71.65 | null | 2021-01-21 | 2021-02-15 | Rucaparib | 02 | null | RUCAPARIB | 101583148 |
| 230001987 | 230008208 | 1.66 | 56.8 | null | 2017-05-06 | 2017-05-13 | Olaparib | 02 | null | OLAPARIB | 100641405 |
| 230001988 | 230008209 | 1.53 | 50.4 | null | 2019-03-19 | 2019-04-02 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100478120 |
| 230001990 | 230008210 | null | null | null | null | 2017-02-02 | Bevacizumab | 02 | null | BEVACIZUMAB | 101011766 |
| 230001998 | 230008212 | 1.55 | 65 | Palliative (P) | 2020-04-28 | 2020-05-28 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101257381 |
| 230002000 | 230008214 | 1.61 | 78.5 | null | 2017-11-11 | 2017-12-03 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100920536 |
| 230002001 | 230008215 | 1.62 | 91.25 | Neo-adjuvant (N) | null | 2017-08-06 | PACLITAXEL | 02 | N | PACLITAXEL | 101026002 |
| 230002010 | 230008218 | 1.59 | 67.4 | Neo-adjuvant (N) | 2021-04-02 | 2021-04-09 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100796228 |
| 230002021 | 230008221 | 1.65 | 68.4 | null | 2021-11-01 | 2021-11-10 | null | 02 | null | DOXORUBICIN | 100244440 |
| 230002022 | 230008222 | 1.64 | 62.6 | 03 | 2017-10-16 | 2019-06-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101427882 |
| 230002023 | 230008223 | 1.66 | 66.8 | null | 2018-01-15 | 2018-01-20 | Cisplatin | 02 | null | CARBOPLATIN + DOCETAXEL | 101154209 |
| 230002024 | 230008224 | 1.64 | 57.1 | null | 2020-11-18 | 2020-12-10 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101534467 |
| 230002026 | 230008225 | 1.68 | 75 | null | 2021-04-27 | 2021-04-27 | null | null | null | CARBOPLATIN + LIPOSOMAL DOX | 100342444 |
| 230002027 | 230008226 | null | null | Palliative (P) | null | 2020-05-19 | null | 01 | N | PEMBROLIZUMAB | 101310432 |
| 230002031 | 230008227 | 1.6 | 138.6 | Curative (C) | 2020-10-21 | 2021-10-09 | Olaparib | 02 | N | OLAPARIB | 101678575 |
| 230002036 | 230008228 | 1.58 | 84.9 | null | 2021-03-21 | 2021-04-06 | null | null | null | DOXORUBICIN | 100770562 |
| 230002037 | 230008229 | 1.68 | 89.5 | null | 2019-02-20 | 2019-09-16 | null | null | null | CARBOPLATIN | 100762527 |
| 230002043 | 230008230 | null | null | null | 2019-08-16 | 2019-09-20 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101645607 |
| 230002047 | 230008231 | 1.63 | 78.9 | null | 2021-10-24 | 2021-11-06 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101483966 |
| 230002051 | 230008234 | null | null | null | null | 2020-02-29 | DOXORUBICIN | 01 | null | CARBOPLATIN | 101668059 |
| 230002052 | 230008235 | 1.65 | 64.9 | Palliative (P) | 2019-08-31 | 2019-09-17 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100523092 |
| 230002053 | 230008236 | 1.55 | 61 | Palliative (P) | 2018-08-22 | 2020-12-25 | Olaparib | 02 | N | OLAPARIB | 100269365 |
| 230002054 | 230008237 | 1.6 | 61.8 | null | 2020-01-19 | 2020-02-01 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100789824 |
| 230002064 | 230008239 | 1.7 | 75 | null | 2020-07-16 | 2020-07-18 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100781182 |
| 230002065 | 230008240 | 1.47 | 66.55 | null | null | 2017-02-18 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101004899 |
| 230002067 | 230008241 | 1.57 | 71.3 | null | 2019-06-09 | 2019-06-15 | Bevacizumab | 02 | null | CISPLATIN + ETOPOSIDE | 101408196 |
| 230002068 | 230008242 | 1.68 | 97.3 | 03 | 2022-03-30 | 2022-05-26 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101506674 |